Treatment of giant cell myocarditis (GCM) can require bridging to orthotopic heart
transplantation (OHT) or recovery with mechanical circulatory support (MCS). Since the roles …

Background Giant cell myocarditis (GCM) is a lethal, rapidly progressive disease, for which
heart transplantation is the treatment of choice. We sought to describe the characteristics …

Giant cell myocarditis (GCM) is a rare form of acute myocarditis generally presenting with
ventricular arrhythmias, acute heart failure (HF) or cardiogenic shock [1]. Histology is …

Background: The therapeutic strategy for giant cell myocarditis (GCM) remains controversial,
so we reviewed the clinical status of Japanese patients with GCM. Methods and Results: We …

Giant cell myocarditis (GCM) is a rare, often rapidly progressive, and potentially fatal disease
because of myocardium inflammation due to the infiltration of giant cells triggered by …

Giant cell myocarditis is a rare but often devastating diagnosis. Advances in cardiac imaging
and mechanical circulatory support have led to earlier and more frequent diagnoses and …

Aims Giant cell myocarditis (GCM) carries a poor prognosis and many patients require end‐
stage therapies. This study sought to determine the outcome of patients bridged with …

Lower recurrence rates and improved long-term outcomes are the goal of treatment for giant
cell myocarditis (GCM). We describe a case of GCM in an Asian woman who presented with …

Aims Giant-cell myocarditis (GCM) is a rare and often fatal form of myocarditis. Only a few
reports have focused on fulminant forms. We describe the clinical characteristics …

Background Giant cell myocarditis (GCM) is a rare but well-known cause of fulminant
myocarditis. Despite optimal medical therapy, many patients progress to orthotopic heart …